Listen as Amanda Kaczerski and Mahire Bonomo, Executive Director at the Center for Continuing Medical Education at The University of Chicago discuss getting a QI program off the ground. The University of Chicago Medicine and Ingalls Memorial Hospital are embarking on a quality improvement (QI) program to explore how strategies applied at a local level can address disparities in care. The project, led by renowned faculty Olufunmilayo Olopade, MD, FACP, is studying the effectiveness of targeted interventions in improving various facets of breast cancer care for African American women treated in Cook County. To learn more, visit fightingBCdisparities.com
Author: Editor
The University of Chicago Medicine and Ingalls Memorial Hospital are embarking on a quality improvement (QI) program to explore how strategies applied at a local level can address disparities in care. The project, led by renowned faculty Olufunmilayo Olopade, MD, FACP, is studying the effectiveness of targeted interventions in improving various facets of breast cancer care for African American women treated in Cook County. To learn more, visit fightingBDdisparities.com
Dr. John Stewart from the Louisiana State University School of Medicine discusses navigating complex treatment. The University of Chicago Medicine and Ingalls Memorial Hospital are embarking on a quality improvement (QI) program to explore how strategies applied at a local level can address disparities in care. The project, led by renowned faculty Olufunmilayo Olopade, MD, FACP, is studying the effectiveness of targeted interventions in improving various facets of breast cancer care for African American women treated in Cook County. To learn more, visit fightingBCdisparities.com
The University of Chicago Medicine and Ingalls Memorial Hospital are embarking on a quality improvement (QI) program to explore how strategies applied at a local level can address disparities in care. The project, led by renowned faculty Olufunmilayo Olopade, MD, FACP, is studying the effectiveness of targeted interventions in improving various facets of breast cancer care for African American women treated in Cook County. To learn more, visit fightingBCdisparities.com
Dr. Monical Peek from The University of Chicago discusses women’s fears and racial health inequities as part of a quality improvement program “Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago.†Led by Olufunmilayo Olopade, MD, FACP, this initiative is studying the effectiveness of targeted interventions in improving breast cancer care for African American women treated in Cook County. Learn more at fightingBCdisparities.com
The University of Chicago Medicine and Ingalls Memorial Hospital are embarking on a quality improvement (QI) program to explore how strategies applied at a local level can address disparities in care. The project, led by renowned faculty Olufunmilayo Olopade, MD, FACP, is studying the effectiveness of targeted interventions in improving various facets of breast cancer care for African American women treated in Cook County. To learn more, visit fightingBCdisparities.com
Lisocabtagene Maraleucel has been approved by the FDA for the second-line treatment of large B cell lymphoma LBCL Lisocabtagene Maraleucel Key Statistics: 65% risk reduction of event-free survival in the Lisocabtagene Maraleucel arm. 10.1 months (95% confidence interval: 6.1, not evaluable) estimated median event-free survival compared to 2.3 months (95% confidence interval: 2.2, 4.3). 59% risk reduction in progression-free survival in the Lisocabtagene Maraleucel arm compared to standard of care. Lisocabtagene Maraleucel is not approved to treat people with primary central nervous system lymphoma. Hazard ratio (HR) of 0.34 (95% CI:0.22, 0.52; p-value0.0001), event-free survival was substantially longer in the…
Hepion Pharmaceuticals Inc Lead Therapy, Rencofilstat Approved for FDA Orphan Drug Designation  Some of the leading causes of liver cancer, which is called Hepatocellular Carcinoma, we call it. Oftentimes, just because HCC is a bit of a multiple, we just refer to it as HCC. You hear me talking about the treatment of Hepatocellular Carcinoma (HCC), one of the leading causes of HCC development. In the Western world, particularly if we look at the US or look at parts of Europe, the leading cause would be something called NASH. What is NASH? NASH is another liver disease. NASH stands…
Dr. Nan Chen from the University of Chicago Medicine shares a status update from ASCO on the quality improvement program “Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago.†Led by Olufunmilayo Olopade, MD, FACP, this initiative is studying the effectiveness of targeted interventions in improving breast cancer care for African American women treated in Cook County.Learn more at fightingBCdisparities.com
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the ALK/ROS1 breakout session, Drs. Jessica Lin and Chul Kim discuss what is known about bypass mechanisms (PIK3, MEK, ERK, etc). A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the ALK/ROS1 breakout session, Drs. Jessica Lin and Chul Kim discuss what treatment options are available for ROS1 and ALK cancer that transforms to a neuroendocrine tumor. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Dr. Lyudmila A. Bazhenova discusses KRAS-directed therapies. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Dr. Millie Das discusses new therapies in NTRK, RET, and HER2. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Drs. Lyudmila A. Bazhenova and Millie Das discuss what makes mutations vary. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Drs. Lyudmila A. Bazhenova and Millie Das discuss how a patient with a designated KRAS mutation ensures the best treatment. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Drs. Lyudmila A. Bazhenova and Millie Das discuss how a patient can go about applying for a trial if their physician isn’t advocating for it. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Drs. Lyudmila A. Bazhenova and Millie Das discuss the trials available for NTRK resistant mutation. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Drs. Lyudmila A. Bazhenova and Millie Das discuss what treatment options are available for KRAS K12c Mutation in NSCLC. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Drs. Lyudmila A. Bazhenova and Millie Das discuss if a patient can have multiple mutations and if so, how they are treated. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Drs. Lyudmila A. Bazhenova and Millie Das discuss the difference between tissue and liquid biopsies. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Drs. Lyudmila A. Bazhenova and Millie Das discuss whether a patient whose tumor has been removed should get molecular testing. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Drs. Lyudmila A. Bazhenova and Millie Das discuss what is the recommended first-line treatment for KRAS K12c? A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the KRAS and Rare Tumor breakout session, Drs. Lyudmila A. Bazhenova and Millie Das discuss recommendations on whether or not to wait for an NGS panel result for a newly diagnosed patient with a 90% PDL1 expression. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more,…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the PM session of the event, Drs. Ben Levy, Jack West and Zosia Piotrowska discuss if there is ever a role for single-agent immunotherapy in driver mutation-positive patients. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the PM session of the event, Drs. Ben Levy, Jack West and Zosia Piotrowska discuss first treatment recommendations for a patient with KRAS G12c, heavy smoker with 90% PDL1 expression. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation,…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the PM session of the event, Drs. Ben Levy, Jack West and Zosia Piotrowska discuss if there is a role for chemo plus immunotherapy in patients with EGFR Mutations and if so, when? A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the PM session of the event, Drs. Ben Levy, Jack West, and Zosia Piotrowska discuss if there will ever be an Opportunity to Use TKI + IO together. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the PM session of the event, Dr. Jared Weiss discusses the role of chemotherapy in driver-positive patients. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the PM session of the event, Dr. Zosia Piotrowska discusses genotype-directed therapies and their role in earlier-stage disease. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the PM session of the event, Dr. Ticiana Leal discusses targeted therapies in oligometastatic disease. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. In this video, from the PM session of the event, Gina Hollenbeck discusses online communities and support, and the importance of education and partnership in research. A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the AM Panel discussion on Early Stage NSCLC with H. Jack West, MD, and Drs. Estelamari Rodriguez, Riyaz Shah, and Narjust Duma, the doctors discuss molecular testing in potentially resectable NSCLC and unresectable locally advanced NSCLC. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the AM Panel discussion on Early Stage NSCLC with H. Jack West, MD, and Drs. Estelamari Rodriguez, Riyaz Shah, and Narjust Duma, the doctors discuss molecular testing and differences by histology and/or smoking status. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join the conversation,…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the AM Panel discussion on Early Stage NSCLC with H. Jack West, MD, and Drs. Estelamari Rodriguez, Riyaz Shah, and Narjust Duma, the doctors discuss broad moleular testing in stage lll unresectable disease. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join the conversation, visit…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the AM Panel discussion on Early Stage NSCLC with H. Jack West, MD, and Drs. Estelamari Rodriguez, Riyaz Shah, and Narjust Duma, the doctors discuss molecular testing, PDL1 and Imfinzi/Durvalumab. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the AM Panel discussion on Early Stage NSCLC with H. Jack West, MD, and Drs. Estelamari Rodriguez, Riyaz Shah, and Narjust Duma, the doctors discuss immunotherapy in PDL1 and EGFR. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the AM Panel discussion on Early Stage NSCLC with H. Jack West, MD, and Drs. Estelamari Rodriguez, Riyaz Shah, and Narjust Duma, the doctors discuss anticipated surgery and the effect on a pneumonectomy recommendation. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join the conversation,…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the AM Panel discussion on Early Stage NSCLC with H. Jack West, MD, and Drs. Estelamari Rodriguez, Riyaz Shah, and Narjust Duma, the doctors discuss surgical vs non-surgical treatment in early nsclc. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the AM Panel discussion on Early Stage NSCLC with H. Jack West, MD, and Drs. Estelamari Rodriguez, Riyaz Shah, and Narjust Duma, the doctors discuss neoadjuvant therapy vs. adjuvant therapy, and where it fits now. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join the…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the AM Panel discussion on Early Stage NSCLC with H. Jack West, MD, and Drs. Estelamari Rodriguez, Riyaz Shah, and Narjust Duma, the doctors discuss the future role of neoadjuvant therapy vs. adjuvant therapy. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join the conversation,…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the AM Panel discussion on Early Stage NSCLC with H. Jack West, MD, and Drs. Estelamari Rodriguez, Riyaz Shah, and Narjust Duma, the doctors discuss circulating tumor DNA for minimal residual disease. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the AM Panel discussion on Early Stage NSCLC with H. Jack West, MD, and Drs. Estelamari Rodriguez, Riyaz Shah, and Narjust Duma, the doctors discuss if we should extrapolate across molecular markers in a curative setting. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD. For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios. In this video, from the second-panel discussion on Advanced NSCLC with Ibiayi Dagogo-Jack, MD, and Drs. Melina Marmarelis, Adrian Sacher, and Aparna Hegde, the panel discuss if broad next-generation sequencing (NGS) is the standard of care. A huge thank you to our sponsor! #takedaoncology For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared Weiss discusses the superior prognosis for HPV-driven head and neck cancers, and their candidacy for reduced intensity. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Many thanks to our sponsor #merck!
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared Weiss makes an argument for reducing the intensity of treatment in some SCCHN patients. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Many thanks to our sponsor #merck!
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared Weiss discusses avoidance of adjuvant radiation treatment. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Many thanks to our sponsor #merck!
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared Weiss discusses how deintensification affects the current standard of care. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Many thanks to our sponsor #merck!
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell Yarbrough discusses HPV and smoking-related head and neck cancers. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Many thanks to our sponsor #merck!
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell Yarbrough discusses the prevalence of HPV-related head and neck cancers, and how to prevent them. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Many thanks to our sponsor #merck!
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell Yarbrough discusses three main treatments of HPV+ Head and Neck Cancers, as well as their side effects. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum. Many thanks to our sponsor #merck!